Relation of Myocardial Contrast-Enhanced T 1 Mapping by Cardiac Magnetic Resonance to Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy

Höke, Ulas; Khidir, Mand J.H.; Geest, Rob J. van der; Schalij, Martin J.; Bax, Jeroen J.; Delgado, Victoria; Marsan, Nina Ajmone

doi:10.1016/j.amjcard.2017.01.023

Cited by 17 publications

(10 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Additional techniques such as native T1 mapping and ECV are promising biomarkers which might help to refine the prognostic risk stratification and the prediction of LVRR (144,145).…”

Section: Prediction Of Left Ventricular Reverse Remodelingmentioning

confidence: 99%

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance

Mitropoulou

Georgiopoulos

Figliozzi

et al. 2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

“…Additional techniques such as native T1 mapping and ECV are promising biomarkers which might help to refine the prognostic risk stratification and the prediction of LVRR (144,145).…”

Section: Prediction Of Left Ventricular Reverse Remodelingmentioning

confidence: 99%

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance

Mitropoulou

Georgiopoulos

Figliozzi

et al. 2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

“…Оба показателя влияют на достижение клинической эффективности имплантируемого устройства. Кроме того, локализация рубца должна учитываться при имплантации электрода, так как установка электрода в зону рубца снижает возможный эффект сердечной ресинхронизирующей терапии (СРТ) [181][182][183][184][185][186][187][188][189][190] 2) фракция выброса левого желудочка ≥50% [191];…”

Section: магнитно-резонансная томография сердцаunclassified

Eurasian Association of Cardiology (Eac)/ National Society of Heart Failure and Myocardial Disease (Nshfmd) Guidelines for the Diagnosis and Treatment of Chronic Heart Failure (2020)

Терещенко¹,

Жиров²,

Uskach

et al. 2020

Evrazijskij kardiologičeskij žurnal

View full text Add to dashboard Cite

Disclaimer The EAC/NSHFMD Guidelines represent the views of the EAC and NSHFMD, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC and NSHFMD is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the EAC/NSHFMD Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the EAC/NSHFMD Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the EAC/NSHFMD Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient’s health condition and in consultation with that patient and, where appropriate and/or necessary, the patient’s caregiver. Nor do the EAC/NSHFMD Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient’s case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional’s responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.Members of the Working Group confirmed the lack of financial support/ conflict of interest. In the event of a conflict of interest being reported, the member (s) of the Working Group was (were) excluded from the discussion of sections related to the area of conflict of interest.E.B. Wataman professor, Dr. of Sci. (Med.) (Moldova); E.K. Kurlyanskaya, Cand. of Sci. (Med.) (Belarus); A.M. Noruzbaeva professor (Kyrgyzstan); V.A. Azizov professor (Azerbaijan); Zelveyan P.A., Dr. of Sci. (Med.) (Armenia)

show abstract

“…Techniques such as LGE quantification and the more recent diffuse fibrosis assessment by Extra Cellular Volume and T1 mapping evaluation have been developed to go beyond this limitation. Such technologies must be perfected in order to improve reproducibility and standardization, but they are absolutely promising [13,14].…”

Section: Prediction Of Lvrr: the Leading Role Of Cardiac Magnetic Resmentioning

confidence: 99%

Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives

Masè

Merlo

Vitrella

et al. 2018

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Relation of Myocardial Contrast-Enhanced T 1 Mapping by Cardiac Magnetic Resonance to Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy

Cited by 17 publications

References 30 publications

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance

Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance

Eurasian Association of Cardiology (Eac)/ National Society of Heart Failure and Myocardial Disease (Nshfmd) Guidelines for the Diagnosis and Treatment of Chronic Heart Failure (2020)

Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives

Contact Info

Product

Resources

About